ArticlePharmaceutics2022

Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies.

Rajbharan Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.